Sign In
BCS.US
id: 1204

Barclays PLC (BCS) Investor Settlement

The case has been dismissed, typically without any further action.
S.D. New York
Court
1:24-cv-01872
Case number
02/18/2021
Class period Start
02/14/2023
Class period End
Barclays reached a settlement with $BCS investors over claims that it sold $17 billion in unregistered securities, resulting in restated financials and a halt in VXX ETNs sales.

Case Details:

Barclays had not implemented any internal controls to monitor the issuance of securities from its shelf registrations.

With absense of proper controls, Barclays sold $17 billion of unregistered securities over 18 months in violation of the federal securities registration laws.

When this information came to light, Barclays had to suddenly suspend issuances and sales of new VXX ETNs.

Upon suspension of sales, $VXX increased 9%+, hurting investors who were short $VXX.
Case Status
Dismissed
Alleged Offence
Misleading Statements
Failure to Disclose
Omissions
Suspected Party
Directors
Management
Security Type
Stocks
Trade Direction
Short
Filing date
03/12/2024
Lead Plaintiff Deadline
05/17/2024
Plaintiffs
Michael Puchtler
Attorneys
Kaplan Fox & Kilsheimer, LLP (New York, NY), Sperling & Slater, P.C. (Chicago, IL)
Defendants
James E. Stanley, Tushar Morzaria, C.S. Venkatakrishnan
Judge
Hon. Katherine Polk Failla
Trades matching type
FIFO

Barclays PLC ADR

Barclays PLC provides various financial services in the United Kingdom, Europe, the Americas, Africa, the Middle East, and Asia. The company operates through Barclays UK; Barclays UK Corporate Bank...

    Ticker
    BCS.US
    ISIN
    US06738E2046
    CIK
    0000312069
    Sector
    Financial Services
    Industry
    Banks - Diversified
    Country
    USA
    Address
    1 Churchill Place, London, United Kingdom, E14 5HP